Idiopathic pulmonary fibrosis (IPF) is a progressive age-related lung disease, the cause of
which is not been fully understood. IPF is a devastating disease with mortality worse than …

Interstitial lung disease (ILD) is a common manifestation in connective tissue diseases
(CTD), such as rheumatoid arthritis (RA), systemic sclerosis (SSc), and inflammatory …

Background: In the past two decades, many advances have been made to our
understanding of interstitial lung disease (ILD) and the way we approach its treatment …

Over 200 interstitial lung diseases, from ultra rare to relatively common, are recognised.
Most interstitial lung diseases are characterised by inflammation or fibrosis within the …

IPF is a chronic disease characterized by progressive loss of lung tissue 1, 2, 3. Although
several risk factors have been described [4], the triggers and causes of IPF remain unknown …

Interstitial lung diseases (ILDs) are a heterogeneous group of> 100 pulmonary disorders.
ILDs are characterized by an irreversible architectural distortion and impaired gas …

Fibrotic interstitial lung diseases (ILDs) frequently have nonspecific and overlapping clinical
and radiological features, resulting in∼ 10–20% of patients with ILD lacking a clear …

Interstitial lung disease (ILD) comprises a heterogenous group of diffuse lung disorders that
commonly result in irreversible pulmonary fibrosis. While idiopathic pulmonary fibrosis (IPF) …

Rheumatoid arthritis (RA) is a chronic autoimmune multisystem inflammatory disease in
which lung involvement is the most common extra-articular manifestation. Parenchymal lung …

The pathogenesis of pulmonary fibrosis, including idiopathic pulmonary fibrosis (IPF) and
other forms of interstitial lung disease, involves a complex interplay of various factors …